Articles:

SP Glasser

The relevance of T-type calcium antagonists: a profile of mibefradil
J Clin Pharmacol 1998 38: 659. [Abstract] [PDF]  

SP Tofovic, RA Branch, EK Jackson, MD Cressman, and Kost CK, Jr

Teaching clinical pharmacology and therapeutics: selective for fourth-year medical students
J Clin Pharmacol 1998 38: 670. [Abstract] [PDF]  

I Meineke and CH Gleiter

Assessment of drug accumulation in the evaluation of pharmacokinetic data
J Clin Pharmacol 1998 38: 680. [Abstract] [PDF]  

DA Smith, EW Cleary, S Watkins, CS Huffman, SC Dilzer, and KC Lasseter

Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study
J Clin Pharmacol 1998 38: 685. [Abstract] [PDF]  

R Dixon, S French, J Kemp, M Sellers, V Leclerc, M Delvaux, and J Rautureau

Effect of hepatic impairment on the pharmacokinetics of zolmitriptan
J Clin Pharmacol 1998 38: 694. [Abstract] [PDF]  

NN Vachharajani, WC Shyu, TJ Chando, DW Everett, DS Greene, and RH Barbhaiya

Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers
J Clin Pharmacol 1998 38: 702. [Abstract] [PDF]  

BE Bleske, LS Welage, WG Kramer, and JM Nicklas

Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure
J Clin Pharmacol 1998 38: 708. [Abstract] [PDF]  

A Mazzu, J Lettieri, L Kaiser, W Mullican, and AH Heller

Influence of age on the safety, tolerability, and pharmacokinetics of the novel HMG-CoA reductase inhibitor cerivastatin in healthy male volunteers
J Clin Pharmacol 1998 38: 715. [Abstract] [PDF]  

U Ebert, M Siepmann, R Oertel, KA Wesnes, and W Kirch

Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration
J Clin Pharmacol 1998 38: 720. [Abstract] [PDF]  

DM Colussi, CY Parisot, and GY Lefevre

Plasma protein binding of letrozole, a new nonsteroidal aromatase enzyme inhibitor
J Clin Pharmacol 1998 38: 727. [Abstract] [PDF]  

GJ Moyle, M Youle, C Higgs, J Monaghan, W Prince, S Chapman, N Clendeninn, and MR Nelson

Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus
J Clin Pharmacol 1998 38: 736. [Abstract] [PDF]  

M Osman, A Chandrasekaran, K Chan, J Scatina, J Ermer, W Cevallos, and SF Sisenwine

Metabolic disposition of 14C-bromfenac in healthy male volunteers
J Clin Pharmacol 1998 38: 744. [Abstract] [PDF]  

RH Stern, JA Smithers, and SC Olson

Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine
J Clin Pharmacol 1998 38: 753. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.